We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Showcases Broad Portfolio of Integrated IVD Solutions at EUROMEDLAB Munich

By LabMedica International staff writers
Posted on 11 Apr 2022

Siemens Healthineers (Erlangen, Germany) showcased its broad portfolio of integrated IVD solutions at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany. More...

At EUROMEDLAB Munich, Siemens demonstrated it automation solutions for labs of all sizes that are fully scalable, innovative, and customized for individual workflows. Siemens demonstrated how labs could achieve open, one-touch, end-to-end testing with its Aptio Automation solution and drive open, one-touch sample preparation for multidisciplinary labs with its Atellica Task Targeted Automation solution. The company also demonstrated how its Atellica Integrated Automation solution could streamline the biggest chemistry and immunoassay workloads for laboratories.

The company showcased its two new high-volume hematology analyzers - Atellica HEMA 570 and 580 - designed to meet the hematology testing needs of today’s high-volume labs. Sharing fast throughput and an identical footprint, both instruments are intended to pair with advanced informatics and automation solutions to suit diverse workflow requirements and drive efficiencies across labs and networks. Each delivers a range of analytical capabilities, including an 8-part white blood cell differential, with the Atellica HEMA 580 Analyzer offering an expanded menu complete with optical platelet and reticulocyte testing. In addition, Siemens highlighted its epoc Blood Analysis System with epoc NXS Hos, the market-first Android powered patient-side testing solution. epoc is a handheld, wireless solution to enable comprehensive blood analysis testing at the patient’s side on a single room temperature test card, with results in less than a minute.

Siemens also displayed the Dimension EXL 200 Integrated Chemistry System which can simplify operations with an integrated chemistry and immunoassay analyzer in a compact footprint. Also on display were the Sysmex CN-3000 and CN-6000 fully automated, mid- and high-volume coagulation analyzers that are designed to tackle big lab challenges. In addition, Siemens exhibited the new Atellica DCA connected, scalable, and portable analyzer that can collect actionable HbA1c and ACR results in minutes, alongside the Atellica CI 1900 System which is being developed for lower- to mid-volume laboratories. Among its high-performing assays, Siemens showcased the breadth and depth of its clinical menu from cardiac and allergy testing to dedicated plasma protein/FLC to real-time PCR testing for SARS-CoV-2, new preeclampsia markers and more.

Related Links:
Siemens Healthineers 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.